JCD – Vol 2 – Issue 1

rsz_cover_jcd_vol_2_no_1_2015-page-001

Potential Benefits and Concerns with Measuring 1, 5-Anhydroglucitol as a Marker of Glycemia

Nishita Meshram, Dr. Manish Bothale, Dr. Unnikrishnan AG

 

Levels of 1, 5-anhydroglucitol (1,5-AG) have long been postulated to be a measure of post-meal
glucose excursion and 1,5-AG existsin a large pool in our body. In case of glucosuria due to hyperglycemia
the renal tubular reabsorption of 1,5-AG is inhibited and its concentration in the serum decreases. The level
of 1, 5-anhydroglucitol can be an alternative to HbA1c, which is a standard index for glycemic control, and
for monitoring the pattern of glycemic excursions in patients with well-controlled and moderately controlled
type 2 diabetes. The 1, 5-­AG assay reflects glycemic excursions in the postprandial state more precisely than
some other methods available for the same. A test for measuring 1, 5-AG has received US FDA approval
for monitoring short-term glycemic control as early as in 2003. This article refers to the source of 1, 5-AG,
its structural similarity to glucose, its measurement, its role in improving patient care and future aspects as
well as concerns.

 

Read Full Article

 

Pathophysiology of Insulin Resistance

Dr. Shalini Jaggi, Dr. Sudhish Sehra, Dr. Devendra Sehra

 

Insulin resistance is the reduced ability of insulin to perform its normal physiological functions, and hence greater than normal amount of insulin is eventually required to obtain a quantitatively normal biological response.

 

Read Full Article

 

Management of Adult Diabetic Patients Undergoing Surgery

Prof. Arvind Mishra, Dr. Varun Kumar Singh, Prof. Ravi Misra, Dr. Shilpa

 

Diabetes seriously interferes with surgical procedures and in turn surgery also seriously interferes with diabetic control. Metabolic perturbations observed as release of stress hormones added up with marked insulin resistance lead to altered glucose homeostasis resulting in severe hyperglycemia. Associated comorbid states  further  fuel  this  prevailing  volatile  state.  Added  to  this  misery  is  lack  of  definite  guidelines  regarding   acceptable glycemic range in perioperative period. Also relation of glycemic state to wound healing and various insulin regimen is not established so far. A very clear, logical, calculated and planned strategy remains the  need  of  the  time  to  sail  through  this  difficult  and  unpredictable  situation.  The  management  goal  is  to   optimize  metabolic  control  through  close  monitoring,  adequate  fluid  and  calorie  repletion,  judicious  use  of   insulin to maintain desirable glycemic state and avoidance of hypoglycemia.

 

Read Full Article

 

Pioglitazone and Bladder Cancer in India, a Real Threator Man-Made Fiasco: A Review

Prithwijit Banerjee, Karthik VP, Kishan PV

 

Pioglitazone is an oral anti-diabetic agent that, in the presence of insulin resistance, increases hepatic and peripheral insulin sensitivity, thereby inhibiting hepatic gluconeogenesis and increasing peripheral and splanchnic glucose uptake. Pioglitazone is generally well tolerated; however some preclinical in vivo studies and limited human data suggest a possible increased risk of bladder cancer with pioglitazone therapy. Therefore, we sought to perform a systematic review to evaluate the magnitude of this association and the quality of the supporting evidence. Based on the available data, pioglitazone still appeared to be an important option either as monotherapy or in combination, considering its efficacy, safety and cost especially among Indians diabetic patients. Good glycemic control is more important than routine cystoscopy among the pioglitazone users, although patients complaining of urinary symptoms must undergo detailed investigations for bladder cancer. Of course, individuals with any bladder malignancy, stand as a contraindication to initiate pioglitazone.

 

Read Full Article

 

Overweight and Obesity Among Hospital in-Patients

Lakshmi Gumpeny, YJ Visweswara Reddy, GR Sridhar, Suresh Krishnamurty

 

Obesity is well known to be associated with adverse health events. However, there is little information about prevalence of overweight and obesity in individuals who are admitted for management of medical conditions. To provide initial data on the pattern of overweight and obesity among those admitted in a medical unit from a medical college located in a rural area of southern India, the present study was carried out. 

 

Read Full Article

 

Pattern of Loss of Glycemic Control in Indian Type 2 Diabetes Patients: An Observational Study

Dr. Manoj Chawla

 

The aim of the study was to determine pattern of loss of glycemic control in Indian type 2 diabetes patients. Methods: An observational registry, the study included 64 type 2 diabetes patients, divided in four groups based  on  baseline  HbA1c  values:  group  1  (<6.5%,  n  =  17),  2  (6.5-­6.9%,  n  =  11),  3  (7.0-­7.9%,  n  =  21),  4  (e”   8%,  n  =  15).

 

Read Full Article

 

Correlation of Inflammatory Markers and Dyslipidemia with Carotid Intima-Media Thickness in Type 2 Diabetic Subjects

Mukhopadhyay Saptarshi, Banerjee Samar, Bhattacharya Kingshuk

 

Creactive protein (CRP) and ESR are well-­known inflammatory markers. Dyslipidemia are potent risk factors for cardiovascular disease, and carotid intima-medial thickness (CIMT) denotes subclinical atherosclerosis. Our aim was to assess the correlation between them in diabetic subjects. Materials and Methods: In this prospective observational study, we selected 78 subjects with type 2 diabetes and dyslipidaemia. The study period was 6 months. Carotid intima-­medial thickness of the subjects was measured. The values correlated with the risk markers.

 

Read Full Article

 

Journal Watch

 

The risk for development of T2DM in patients after gestational diabetes (GDM) is well established. But the researchers here studied the impact of high maternal weight on further cardiovascular disease in a population of more than 240,000 Canadian singleton deliveries over 10 years.T2DM developed in 36% of overweight patients who had GDM, 18.8% of patients who only had GDM, and 4.8% of patients who were only overweight. A similar pattern was seen in the development of hypertension and cardiovascular disease in these groups. High maternal weight and GDM were independent risk factors for hypertension and cardiovascular disease, but high maternal weight compared to GDM appears to be stronger.

 

Read Full Article

 

Quiz

Read Full Article 

 

Announcement

Read Full Article

Proudly powered by WordPress   Premium Style Theme by www.gopiplus.com